Trump Administration Commits $48.5 Million to Assist States with Substance Use Disorder Treatment and Recovery

Today, the Trump Administration announced planning grant awards to 15 state Medicaid agencies to increase the treatment capacity of providers to furnish substance use disorder (SUD) treatment and recovery services. Fighting the opioid epidemic is one of CMS’s top priorities, and the planning grants are an important step in that effort.

The planning grants are intended to increase the capacity of Medicaid providers to deliver SUD treatment or recovery services through: an ongoing assessment of the SUD treatment needs of the State; recruitment, training, and technical assistance for Medicaid providers that offer SUD treatment or recovery services; and improved reimbursement for and expansion of the number or treatment capacity of Medicaid providers. CMS awarded approximately $48.5 million to the following state Medicaid agencies: Alabama, Connecticut, Delaware, District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington, West Virginia.

The planning grants awards are the next step in CMS’s implementation of section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act (P.L. 115-271) and associated funding represents a key aspect of our efforts to increase access to evidence-based treatment for Opioid Use Disorder.

More information on Medicaid.gov.